AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.219
+0.006 (2.57%)
At close: Jan 21, 2025, 4:00 PM
0.233
+0.014 (6.43%)
After-hours: Jan 21, 2025, 7:57 PM EST
AIM ImmunoTech Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for AIM ImmunoTech stock have an average target of 2.75, with a low estimate of 1.00 and a high estimate of 4.50. The average target predicts an increase of 1,153.99% from the current stock price of 0.22.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 10, 2024.
Analyst Ratings
The average analyst rating for AIM ImmunoTech stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $5 → $4.5 | Strong Buy | Maintains | $5 → $4.5 | +1,951.98% | Dec 10, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $2 → $1 | Strong Buy | Maintains | $2 → $1 | +356.00% | Oct 22, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $5.25 → $5 | Strong Buy | Maintains | $5.25 → $5 | +2,179.98% | Sep 3, 2024 |
Financial Forecast
Revenue This Year
146.45K
from 202.00K
Decreased by -27.50%
Revenue Next Year
2.63M
from 146.45K
Increased by 1,693.10%
EPS This Year
-0.34
from -0.60
EPS Next Year
-0.41
from -0.34
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 210,000 | 5.3M | 7.9M | |||
| Avg | 146,450 | 2.6M | 7.6M | |||
| Low | 88,200 | 196,000 | 7.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 4.0% | 3,484.8% | 199.9% | |||
| Avg | -27.5% | 1,693.1% | 188.5% | |||
| Low | -56.3% | 33.8% | 179.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.28 | -0.41 | -0.47 | |||
| Avg | -0.34 | -0.41 | -0.46 | |||
| Low | -0.38 | -0.44 | -0.45 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.